(ADM) Archer-Daniels-Midland - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0394831020
Stock:
Total Rating 47
Risk 84
Buy Signal 0.25
| Risk 5d forecast | |
|---|---|
| Volatility | 27.7% |
| Relative Tail Risk | -9.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 44.77 |
| Character TTM | |
|---|---|
| Beta | 0.398 |
| Beta Downside | 0.920 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.22% |
| CAGR/Max DD | -0.04 |
EPS (Earnings per Share)
Revenue
Description: ADM Archer-Daniels-Midland
Archer-Daniels-Midland Company provides human and animal nutrition ingredients and solutions in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. It operates in three segments: Ag Services and Oilseeds; Carbohydrate Solutions; and Nutrition. The company engages in the origination, merchandising, transportation, and storage of agricultural raw materials, as well as the crushing and processing of oilseeds, including soybeans and soft seeds, such as cottonseed, sunflower seed, canola, rapeseed, and flaxseed; produces and markets vegetable oils and oilseed protein meals used by food, feed, energy, and industrial customers; sale of crude and partially refined vegetable oils; supplies peanuts and peanut-derived ingredients; and manufactures cotton cellulose pulp. It is also involved in the grain sourcing, handling, and multimodal transportation network supporting import, export, and distribution activities; structured trade finance activities; corn and wheat wet and dry milling and related processing activities; production of distillers' grains, corn gluten feed, and corn gluten meal for use as animal feed ingredients; and carbon capture and sequestration and other emissions-reduction initiatives. In addition, the company engages in the creation, manufacturing, sale, and distribution of an array of ingredients and solutions comprising plant-based proteins, flavors and colors derived from nature, flavor systems, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, postbiotics, enzymes, botanical extracts, and other specialty food and feed ingredients and systems. Further, it is involved in the derivatives and commodity exchanges and clearing houses; and insurance coverage for certain property, casualty, marine, medical, and other miscellaneous risks. The company was founded in 1902 and is based in Chicago, Illinois.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.08b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 9.82 > 1.0 |
| NWC/Revenue: 10.13% < 20% (prev 9.10%; Δ 1.04% < -1%) |
| CFO/TA 0.16 > 3% & CFO 5.45b > Net Income 1.08b |
| Net Debt (7.39b) to EBITDA (3.87b): 1.91 < 3 |
| Current Ratio: 11.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (484.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 5.80% > 18% (prev 0.07%; Δ 573.4% > 0.5%) |
| Asset Turnover: 182.6% > 50% (prev 160.6%; Δ 22.07% > 0%) |
| Interest Coverage Ratio: 3.16 > 6 (EBITDA TTM 3.87b / Interest Expense TTM 580.0m) |
Altman Z'' 7.92
| A: 0.23 (Total Current Assets 8.94b - Total Current Liabilities 798.0m) / Total Assets 34.66b |
| B: 0.63 (Retained Earnings 21.98b / Total Assets 34.66b) |
| C: 0.04 (EBIT TTM 1.83b / Avg Total Assets 43.97b) |
| D: 3.84 (Book Value of Equity 44.72b / Total Liabilities 11.63b) |
| Altman-Z'' Score: 7.92 = AAA |
Beneish M -3.03
| DSRI: 0.54 (Receivables 3.02b/5.95b, Revenue 80.29b/85.53b) |
| GMI: 1.16 (GM 5.80% / 6.76%) |
| AQI: 1.67 (AQ_t 0.42 / AQ_t-1 0.25) |
| SGI: 0.94 (Revenue 80.29b / 85.53b) |
| TATA: -0.13 (NI 1.08b - CFO 5.45b) / TA 34.66b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of ADM shares?
As of March 03, 2026, the stock is trading at USD 69.61 with a total of 2,221,506 shares traded.
Over the past week, the price has changed by +2.84%, over one month by +3.02%, over three months by +16.29% and over the past year by +54.71%.
Over the past week, the price has changed by +2.84%, over one month by +3.02%, over three months by +16.29% and over the past year by +54.71%.
Is ADM a buy, sell or hold?
Archer-Daniels-Midland has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold ADM.
- StrongBuy: 1
- Buy: 0
- Hold: 9
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the ADM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60.7 | -12.8% |
| Analysts Target Price | 60.7 | -12.8% |
ADM Fundamental Data Overview February 28, 2026
P/E Trailing = 30.2332
P/E Forward = 12.7877
P/S = 0.4042
P/B = 1.2662
P/EG = 16.4259
Revenue TTM = 80.29b USD
EBIT TTM = 1.83b USD
EBITDA TTM = 3.87b USD
Long Term Debt = 7.61b USD (from longTermDebt, last quarter)
Short Term Debt = 798.0m USD (from shortTermDebt, last quarter)
Debt = 8.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.39b USD (from netDebt column, last quarter)
Enterprise Value = 39.84b USD (32.44b + Debt 8.41b - CCE 1.01b)
Interest Coverage Ratio = 3.16 (Ebit TTM 1.83b / Interest Expense TTM 580.0m)
EV/FCF = 9.48x (Enterprise Value 39.84b / FCF TTM 4.20b)
FCF Yield = 10.55% (FCF TTM 4.20b / Enterprise Value 39.84b)
FCF Margin = 5.24% (FCF TTM 4.20b / Revenue TTM 80.29b)
Net Margin = 1.34% (Net Income TTM 1.08b / Revenue TTM 80.29b)
Gross Margin = 5.80% ((Revenue TTM 80.29b - Cost of Revenue TTM 75.63b) / Revenue TTM)
Gross Margin QoQ = 6.54% (prev 6.23%)
Tobins Q-Ratio = 1.15 (Enterprise Value 39.84b / Total Assets 34.66b)
Interest Expense / Debt = 1.69% (Interest Expense 142.0m / Debt 8.41b)
Taxrate = 4.62% (22.0m / 476.0m)
NOPAT = 1.75b (EBIT 1.83b * (1 - 4.62%))
Current Ratio = 11.20 (Total Current Assets 8.94b / Total Current Liabilities 798.0m)
Debt / Equity = 0.37 (Debt 8.41b / totalStockholderEquity, last quarter 22.73b)
Debt / EBITDA = 1.91 (Net Debt 7.39b / EBITDA 3.87b)
Debt / FCF = 1.76 (Net Debt 7.39b / FCF TTM 4.20b)
Total Stockholder Equity = 22.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 1.08b / Total Assets 34.66b)
RoE = 4.80% (Net Income TTM 1.08b / Total Stockholder Equity 22.44b)
RoCE = 6.11% (EBIT 1.83b / Capital Employed (Equity 22.44b + L.T.Debt 7.61b))
RoIC = 5.54% (NOPAT 1.75b / Invested Capital 31.58b)
WACC = 6.19% (E(32.44b)/V(40.85b) * Re(7.38%) + D(8.41b)/V(40.85b) * Rd(1.69%) * (1-Tc(0.05)))
Discount Rate = 7.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -4.53%
[DCF] Terminal Value 87.39% ; FCFF base≈3.01b ; Y1≈3.72b ; Y5≈6.33b
[DCF] Fair Price = 333.1 (EV 167.69b - Net Debt 7.39b = Equity 160.30b / Shares 481.2m; r=6.19% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -92.41 | EPS CAGR: -18.80% | SUE: -0.15 | # QB: 0
Revenue Correlation: -88.20 | Revenue CAGR: -6.26% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.95 | Chg7d=-0.017 | Chg30d=-0.085 | Revisions Net=-3 | Analysts=9
EPS current Year (2026-12-31): EPS=4.01 | Chg7d=-0.053 | Chg30d=-0.236 | Revisions Net=-8 | Growth EPS=+16.8% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=4.66 | Chg7d=+0.007 | Chg30d=-0.032 | Revisions Net=-2 | Growth EPS=+16.4% | Growth Revenue=+2.4%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.6% (Discount Rate 7.9% - Earnings Yield 3.3%)
[Growth] Growth Spread = -3.9% (Analyst 0.8% - Implied 4.6%)
P/E Forward = 12.7877
P/S = 0.4042
P/B = 1.2662
P/EG = 16.4259
Revenue TTM = 80.29b USD
EBIT TTM = 1.83b USD
EBITDA TTM = 3.87b USD
Long Term Debt = 7.61b USD (from longTermDebt, last quarter)
Short Term Debt = 798.0m USD (from shortTermDebt, last quarter)
Debt = 8.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.39b USD (from netDebt column, last quarter)
Enterprise Value = 39.84b USD (32.44b + Debt 8.41b - CCE 1.01b)
Interest Coverage Ratio = 3.16 (Ebit TTM 1.83b / Interest Expense TTM 580.0m)
EV/FCF = 9.48x (Enterprise Value 39.84b / FCF TTM 4.20b)
FCF Yield = 10.55% (FCF TTM 4.20b / Enterprise Value 39.84b)
FCF Margin = 5.24% (FCF TTM 4.20b / Revenue TTM 80.29b)
Net Margin = 1.34% (Net Income TTM 1.08b / Revenue TTM 80.29b)
Gross Margin = 5.80% ((Revenue TTM 80.29b - Cost of Revenue TTM 75.63b) / Revenue TTM)
Gross Margin QoQ = 6.54% (prev 6.23%)
Tobins Q-Ratio = 1.15 (Enterprise Value 39.84b / Total Assets 34.66b)
Interest Expense / Debt = 1.69% (Interest Expense 142.0m / Debt 8.41b)
Taxrate = 4.62% (22.0m / 476.0m)
NOPAT = 1.75b (EBIT 1.83b * (1 - 4.62%))
Current Ratio = 11.20 (Total Current Assets 8.94b / Total Current Liabilities 798.0m)
Debt / Equity = 0.37 (Debt 8.41b / totalStockholderEquity, last quarter 22.73b)
Debt / EBITDA = 1.91 (Net Debt 7.39b / EBITDA 3.87b)
Debt / FCF = 1.76 (Net Debt 7.39b / FCF TTM 4.20b)
Total Stockholder Equity = 22.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 1.08b / Total Assets 34.66b)
RoE = 4.80% (Net Income TTM 1.08b / Total Stockholder Equity 22.44b)
RoCE = 6.11% (EBIT 1.83b / Capital Employed (Equity 22.44b + L.T.Debt 7.61b))
RoIC = 5.54% (NOPAT 1.75b / Invested Capital 31.58b)
WACC = 6.19% (E(32.44b)/V(40.85b) * Re(7.38%) + D(8.41b)/V(40.85b) * Rd(1.69%) * (1-Tc(0.05)))
Discount Rate = 7.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -4.53%
[DCF] Terminal Value 87.39% ; FCFF base≈3.01b ; Y1≈3.72b ; Y5≈6.33b
[DCF] Fair Price = 333.1 (EV 167.69b - Net Debt 7.39b = Equity 160.30b / Shares 481.2m; r=6.19% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -92.41 | EPS CAGR: -18.80% | SUE: -0.15 | # QB: 0
Revenue Correlation: -88.20 | Revenue CAGR: -6.26% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.95 | Chg7d=-0.017 | Chg30d=-0.085 | Revisions Net=-3 | Analysts=9
EPS current Year (2026-12-31): EPS=4.01 | Chg7d=-0.053 | Chg30d=-0.236 | Revisions Net=-8 | Growth EPS=+16.8% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=4.66 | Chg7d=+0.007 | Chg30d=-0.032 | Revisions Net=-2 | Growth EPS=+16.4% | Growth Revenue=+2.4%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.6% (Discount Rate 7.9% - Earnings Yield 3.3%)
[Growth] Growth Spread = -3.9% (Analyst 0.8% - Implied 4.6%)